PriceTargets.com logo

CNSX:TAAT - Empower Clinics Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.37
  • Forecasted Upside: ∞
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 06/8/2021 03:32 PM ET
+0.30 (1.20%)

This chart shows the closing price for TAAT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Empower Clinics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TAAT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TAAT

Analyst Price Target is $5.37
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Empower Clinics in the last 3 months. The average price target is $5.37, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for TAAT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Empower Clinics.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/7/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/2/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/2/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/1/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/3/2021Fundamental ResearchBoost Price TargetBuy$5.37
6/1/2021Fundamental ResearchInitiated CoverageBuy$5.17
(Data available from 7/1/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/2/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/3/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/2/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/2/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/1/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Empower Clinics logo
TAAT Global Alternatives Inc., through its subsidiary, TAAT International LLC, manufactures and distributes hemp cigarettes under the Wild Hemp brand name in Canada and the United States. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Empower Clinics?

The following sell-side analysts have issued research reports on Empower Clinics in the last twelve months: Fundamental Research.
View the latest analyst ratings for TAAT.

What is the current price target for Empower Clinics?

0 Wall Street analysts have set twelve-month price targets for Empower Clinics in the last year. Their average twelve-month price target is $5.37.
View the latest price targets for TAAT.

What is the current consensus analyst rating for Empower Clinics?

Empower Clinics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TAAT will outperform the market and that investors should add to their positions of Empower Clinics.
View the latest ratings for TAAT.